Treatment Failure of Nelfinavir-Containing Triple Therapy Can Largely Be Explained by Low Nelfinavir Plasma Concentrations-Reference-Cited by-同舟云学术

Treatment Failure of Nelfinavir-Containing Triple Therapy Can Largely Be Explained by Low Nelfinavir Plasma Concentrations

Published:2003-02 Issue:1 Volume:25 Page:73-80
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:Therapeutic Drug Monitoring

Author:

Burger David M.,Hugen Patricia W. H.,Aarnoutse Rob E.,Hoetelmans Richard M. W.,Jambroes Marielle,Nieuwkerk Pythia T.,Schreij Gerrit,Schneider Margriet M. E.,van der Ende Marchina E.,Lange Joep M. A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference23 articles.

1. Indinavir Concentrations and Antiviral Effect

2. Pharmacokinetic strategies for concentration-targeted therapy with zidovudine (ZDV) lamivudine (3TC), and indinavir (IDV)*

3. A Pilot Study of Nevirapine, Indinavir, and Lamivudine among Patients with Advanced Human Immunodeficiency Virus Disease Who Have Had Failure of Combination Nucleoside Therapy

4. Antiviral Effect and Pharmacokinetic Interaction between Nevirapine and Indinavir in Persons Infected with Human Immunodeficiency Virus Type 1

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Drug Monitoring and Clinical Toxicology: Challenges and Future Directions;Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology;2022

2. Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum;The Journal of Clinical Pharmacology;2018-10-25

3. Pharmacokinetics and Pharmacodynamics of Anti-infective Agents;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015

4. Pharmacokinetic targets of antiretroviral therapy in children and adolescents;J PEDIATR NEONATAL I;2013

5. Antiretroviral Therapeutic Drug Monitoring in HIV-Infected Pregnant Women: Maternal Immunovirological Outcome at Delivery and During the 18 Month Follow-Up Period;Current HIV Research;2012-09-30